Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Seelos Therapeutics Inc
(NQ:
SEEL
)
1.280
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Seelos Therapeutics Inc
“Nasdaq Stocks Set for Explosive Growth: BNZI, SEEL, PRSO, MSS, HSCS Revamp for Big Potential”
September 24, 2024
Via
AB Newswire
How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition
January 24, 2024
EQNX::TICKER_START (NYSE:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(NASDAQ:ATAI) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
The Strategic Brilliance of Acquiring High Times IP, Including Existing Licensing Agreements and Royalty Streams in All-Stock Transaction
September 07, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Mind Science Targeting Big Brains and Portfolios
August 02, 2023
Via
AB Newswire
Global Psychedelic Therapeutics Market Size Expected To Reach $13.29 Billion By The Year 2031
July 26, 2023
EQNX::TICKER_START (NYSE:CYBN),NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(OTCQX:NUMIF) EQNX::TICKER_END
Via
FinancialNewsMedia
Psychedelics Are Proving Their Mettle Against Trauma, Anxiety
February 13, 2023
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
Colorado to Vote on Legalizing Psychoactives in November
October 05, 2022
Voters in Colorado will have a say in the legalization of psychedelic drugs this November as an initiative to legalize psilocybin mushrooms and other naturally occurring psychedelics appears on the...
Via
PressReach
Topics
Supply Chain
Exposures
Supply Chain
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
October 05, 2022
A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll...
Via
PressReach
Topics
Cannabis
Exposures
Cannabis
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
October 05, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – October 5, 2022 – A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease,...
Via
FinancialNewsMedia
Topics
Cannabis
Exposures
Cannabis
Psychedelics Use Among Young Adults Reaches All-Time High
September 01, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 1, 2022 – Young adults are using more hallucinogens than ever. According to a National Institute of Health survey,...
Via
FinancialNewsMedia
World’s Richest Man Says Psychedelics Could Make a Real Difference in Mental Health
June 15, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – June 15, 2022 – Elon Musk believes that psychedelics and other plant-based drugs are better than pharma meds in treating a...
Via
FinancialNewsMedia
Oregon to Become the First State to Legally Roll Out Psilocybin
April 28, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 28, 2022 – Oregon is set to become the first US state to market legal psilocybin, the psychoactive substance found in...
Via
FinancialNewsMedia
Topics
Derivatives
ETFs
Exposures
Derivatives
Why Psychedelics Could Soon Replace Antidepressants
April 13, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 13, 2022 – Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults...
Via
FinancialNewsMedia
Demand for Toad Venom Rises Along With the Booming Psychedelics Market
March 30, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 30, 2022 – Depression and anxiety affect millions around the world and the venom of a toad is the latest psychedelic...
Via
FinancialNewsMedia
Psychedelics Offer Hope for Mental Disorders, Addiction
November 03, 2021
Via
Investor Brand Network
Psychedelics Called the ‘Next Frontier’ for Investors, Also Offer Promising Treatments
September 29, 2021
Via
Investor Brand Network
Rising Acceptance For Treating Mental Disorders is Fueling Strong Growth in Psychedelic Drugs Market
October 14, 2021
Palm Beach, FL –October 14, 2021 – FinancialNewsMedia.com News Commentary – Mental disorders are an urgent health crisis worldwide, especially exacerbated by COVID-19. As per a study by Harvard, the...
Via
FinancialNewsMedia
Exposures
COVID-19
$10 Billion Sackler Opioid Settlement Closes Chapter, Psychedelic Chapter Begins
September 15, 2021
Via
FinancialNewsMedia
Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness
July 21, 2021
Via
FinancialNewsMedia
Topics
Law Enforcement
Exposures
Legal
Why North America Region is Dominating the Billion Dollar Psychedelic Drugs Market
October 05, 2021
Palm Beach, FL – October 5, 2021 – FinancialNewsMedia.com News Commentary – The psychedelic drugs market is creating major potential for treatment of mental illnesses, and as a result, it is likely to...
Via
FinancialNewsMedia
Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment
May 20, 2021
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Biotech Companies Driving Psychedelics Industry Forward with Key Research
April 13, 2021
Via
FinancialNewsMedia
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.